Driven by passion, compassion, integrity , values and a deep level connection with people suffering from difficult medical conditions and people making patient outcome improved. Champion of genomic medicine, cell therapy -transformative medicine and look out for investment in new age technologies right from genetic disorders to infectious diseases and broadens the patients' access to transformative or experimental medicine and stage them Recognized as leader in molecular diagnostic product development, biosimilar development, novel drug and with well-documented ability to engage, establish, and grow relationships within & across Academic, Pharma, Biotech, Hospitals, molecular diagnostics labs, KOL, Association and societies and CRO communities. Excellent balance of scientific and business acumen with strong search & evaluation instincts as well as superior alliance management capabilities in oncology. A proven record of significant business generation within the field of molecular diagnostics, biosimilar development, drug discovery in technology solutions, licensing of pre-clinical assets and high value contract research.Proven as a ‘Leader’ by setting a new vision for the work groups and spearhead in that new direction. Establish confidence between the work groups for successful completion of project.Having 12 + years exeperience in corporate in Novel drug discovery, biosimilar development, Molecular Diagnostics, CRISPR-Cas9 screens, combination and immuno-oncology screens, and the development of custom, genetically modified cell lines and animal models & Genomics- cell line development, biomarker discovery(identification and validation of bio-marker for drugs discovery using comprehensive genomic reference databases) and development of various molecular biology kits. Specialties: Innovation, Translation Science &Product Development & Designing , Strategy, New businesses, Licensing/contracts, Technology, commercial performance Business Development, sales & Leadership, molecular diagnostics, Genomics, Gene editing, Next generation sequencing, bioinformatics, big/meta data, Artificial Intelligence(AI), precision/personalized/stratified medicine, patient stratification, new drug discovery , clinical trial and biosimilar development.